Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bawei Tanxiang Wan
- Development stage
- Unknown
- Lead developer
- Xizang Ganlu Tibetan Medicine and Herbal Resources Development
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Bawei Tanxiang Wan is a traditional Tibetan medicine developed and manufactured by Xizang Ganlu Tibetan Medicine. It is an oral herbal pill formulated based on traditional Tibetan medical principles, primarily indicated for the treatment of heart-related conditions. Its clinical applications include managing coronary heart disease, angina pectoris, and associated symptoms such as chest tightness, palpitations, and shortness of breath. In Tibetan medicine theory, it is used to 'clear heart-heat' and 'regulate heart-wind.' The formulation typically consists of eight key ingredients, with sandalwood (*Santalum album*) serving as the primary component. The drug is officially approved in China with the National Drug License Number Z20023197.
- Brand names
- Ganlu
- Other names
- Eight-Flavor Sandalwood PillBawetangxiang Wan八味檀香丸
02
Targets
ESR2 (ERβ)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)FOXO3 (Forkhead box protein O3)Neuraminidase
Beyond the preview
Go deeper on Bawei Tanxiang Wan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bawei Tanxiang Wan.